For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Alectos Therapeutics Inc.

USPTO Granted Patents = 19

% Expired Patents = 63.2

CIPO Patents = 2

EPO Patents = 16

Forward Citations = 44

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

David Jaro Vocadlo (15 out of 22 patents)

4. Harold G Selnick (15 out of 102 patents)

5. Yongbao Zhu (10 out of 19 patents)

6. Ramesh Kaul (8 out of 12 patents)

7. Jianyu Sun (5 out of 25 patents)

8. Kun Liu (5 out of 48 patents)

9. Yaode Wang (4 out of 10 patents)

10. Zhongyong Wei (4 out of 8 patents)

11. Tong-Shuang Li (4 out of 9 patents)

12. Changwei Mu (3 out of 8 patents)

13. Ernest J Mceachern (3 out of 3 patents)

14. Jiang Chang (2 out of 16 patents)

15. Samy Cecioni (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 12528773 - NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF (2026-01-20),

2. 11396522 - Bis-acetal-based substrates for imaging exo-glycosidase activity (2022-07-26),

3. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),

4. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),

5. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),

6. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

7. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),

8. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),

9. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

10. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),

11. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

12. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),

13. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),

14. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),

15. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),

Alectos Therapeutics Inc. is a biotechnology company based in Burnaby, Canada, focused on developing innovative therapeutics for the treatment of various diseases. The company specializes in drug discovery and development, leveraging advanced technologies to create novel solutions that address unmet medical needs. Alectos is particularly engaged in research related to metabolic disorders and other chronic conditions, aiming to improve patient outcomes through targeted therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

19 Patents

#24 in Burnaby

#778 in Canada

#32,592 in the World

Burnaby, Canada

Alectos Therapeutics Inc.

Forward Citations = 44

21 inventors:

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

David Jaro Vocadlo (15 out of 22 patents)

4. Harold G Selnick (15 out of 102 patents)

5. Yongbao Zhu (10 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…